MD Anderson establishes new $50M+ biotech fund to choose the next promising cancer therapies
Researchers at MD Anderson have a new partner to help them get early-stage programs into the clinic.
In conjunction with The Focus Fund, MD Anderson …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
